A carregar...
Impact of NICE guidance on tamoxifen prescribing in England 2011–2017: an interrupted time series analysis
BACKGROUND: Tamoxifen was recommended by NICE in 2013 for chemoprevention of breast cancer, but a recent survey suggested only a quarter of GPs are aware of this. We set out to measure the uptake of tamoxifen, and the alternative raloxifene, in national prescribing data sets. METHODS: Tamoxifen and...
Na minha lista:
| Publicado no: | Br J Cancer |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group UK
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5943266/ https://ncbi.nlm.nih.gov/pubmed/29681615 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-018-0065-2 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|